China Molecular Biology Enzymes, Reagents And Kits Market Size & Outlook

The molecular biology enzymes, reagents and kits market in China is expected to reach a projected revenue of US$ 2,938.1 million by 2030. A compound annual growth rate of 13.5% is expected of China molecular biology enzymes, reagents and kits market from 2023 to 2030.

Revenue, 2022 (US$M)
$1,064.8
Forecast, 2030 (US$M)
$2,938.1
CAGR, 2023 - 2030
13.5%
Report Coverage
China

China molecular biology enzymes, reagents and kits market highlights

  • The China molecular biology enzymes, reagents and kits market generated a revenue of USD 1,064.8 million in 2022 and is expected to reach USD 2,938.1 million by 2030.
  • The China market is expected to grow at a CAGR of 13.5% from 2023 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2022.
  • Enzymes is the most lucrative product segment registering the fastest growth during the forecast period.


Molecular biology enzymes, reagents and kits market data book summary

Market revenue in 2022USD 1,064.8 million
Market revenue in 2030USD 2,938.1 million
Growth rate13.5% (CAGR from 2022 to 2030)
Largest segmentKits & reagents
Fastest growing segmentEnzymes
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits & Reagents, Enzymes
Key market players worldwideThermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega


Other key industry trends

  • In terms of revenue, China accounted for 5.1% of the global molecular biology enzymes, reagents and kits market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China molecular biology enzymes, reagents and kits market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 998.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Molecular Biology Enzymes, Reagents And Kits Market Scope

Molecular biology enzymes, reagents and kits market segmentation & scope
Kits & Reagents
Enzymes
Cloning
Sequencing
PCR
Epigenetics
Restriction Digestion
Other Applications
Pharma & Biotech
Academic & Research
Hospital & Diagnostics
Others

Molecular Biology Enzymes, Reagents And Kits Market Companies

Name Profile # Employees HQ Website

China molecular biology enzymes, reagents and kits market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.


Kits & reagents was the largest segment with a revenue share of 67.4% in 2022. Horizon Databook has segmented the China molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.


China is the fastest growing pharmaceutical market in the world. The country’s pharmaceutical market ranks second in the world. The country has emerged as a strategic player by establishing improved research and development facilities. The expanding pharmaceutical industry in the country is expected to boost the molecular biology enzymes, kits, and reagents market in China.


In addition, increasing investments from global pharmaceutical giants has expected to spur the market growth. For instance, in November 2019, AstraZeneca launched an R&D center and AI Innovation Centre in Shanghai. The company has also partnered with China International Capital to create funds for the investment in Chinese healthcare startups. Such factors favor the market growth in the country.


Moreover, increasing applications and market of molecular diagnostics products in the country is also anticipated to accelerate the market growth. In June 2019, Mobidiag Ltd collaborated with Autobio Diagnostics for the establishment of Automobile Molecular Diagnostics Co., Ltd. Through this, companies accelerated commercialization of selected infectious disease assays and Novodiag platform in the country.

Reasons to subscribe to China molecular biology enzymes, reagents and kits market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China molecular biology enzymes, reagents and kits market databook

  • Our clientele includes a mix of molecular biology enzymes, reagents and kits market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into China molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China molecular biology enzymes, reagents and kits market size, by product, 2018-2030 (US$M)

China Molecular Biology Enzymes, Reagents And Kits Market Outlook Share, 2022 & 2030 (US$M)

China molecular biology enzymes, reagents and kits market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more